FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998420811> ?p ?o ?g. }

• W1998420811 endingPage "1022" @default.
• W1998420811 startingPage "1021" @default.
• W1998420811 abstract "Rossi et al. (1) show that patients suffering from cluster headache (CH) have a greater prevalence of both lifetime sustained intensive use of illicit drugs and of current intensive use of cannabis as compared to healthy controls. At first glance, these findings seem in line with the well-documented abuse of nicotine (80% smokers as compared to 35% in the general population) (2), relatively high coffee consumption and the finding that 26% of cluster patients regularly use cannabis (3). There are conflicting data regarding alcohol consumption, with clinicians and smaller studies reporting significant abuse and a recent study by Schurks et al., who report the opposite (4). There are two immediate concerns that come to mind when discussing these results. One is the interpretation of the concrete findings and the other concerns the consequences of these data when considering the recent hype promoting the use of illicit drugs in CH. Regarding the first issue, it is intriguing that Rossi et al. (1) found that significant misuse of illicit drugs only holds true for male, but not for female cluster patients. One could argue that the sample size of 210 patients (48 females) is too small for proper statistics, but it is more likely that it is indeed the male cluster patients who are more prone to addictive behaviour. Or is it? Regarding another (albeit legal) drug, nicotine, no difference between male and female patients was found. It is a well-known fact that nearly all cluster patients smoke or have smoked at some time in their life (5), which even prompted the notion that there may be a shared genetic background. Regarding alcohol consumption, it has been suggested that CH seems to protect against hazardous alcohol consumption (4), as it triggers attacks. However, another explanation could be a reporting bias, as all patients know that alcohol triggers attacks and for these reasons do not wish to let the physicians know that they may drink alcohol at all. Along the same line of thought, most cluster patients who indeed consume cannabis or illicit drugs excuse this behaviour with the supposed positive effects of these drugs on CH. The line of argument being that the respective drug is only consumed because of attack or pain reduction. However, in a well-balanced and cautious discussion, Rossi et al. (1) interpret their data that CH patients are prone to overindulge in addictive behaviours (both tobacco and illicit drug use), possibly due to a common biological susceptibility that predisposes them to both CH and addiction. This is certainly supported by the fact that no significant difference was found between episodic and chronic patients nor between the active phase and the remission phase in any of the illicit drug use parameters considered and the fact that the age at first use of cannabis, cocaine and opioids was significantly lower in CH patients than in the control group. More than 70% of the patients started the use of illicit drugs before the outbreak of the first cluster symptoms. Somehow or other, it seems that addiction as such may be more common in CH patients than in the general population. The second point is what to make of these data in light of recent efforts in promoting the use of illicit drugs in CH. A very recent article in Cephalalgia found a positive effect of BOL-148, an analogue of LSD (6). It was an open case series in five patients (one episodic CH) with three patients not having tried any other preventative than Verapamil 240mg in the past. Two of the authors reported a conflict of interest. Although the title suggests that BOL-148 is non-hallucinogenic, the authors stated that: ‘most of the patients recorded some kind of ‘‘flabby’’ or ‘‘light drunk’’ feelings’. Moreover, Tfelt-Hansen (7) pointed out that this substance may not be so harmless, a notion that was already published in 1958 (8) by a pupil of Wolff. In" @default.
• W1998420811 created "2016-06-24" @default.
• W1998420811 creator A5009170730 @default.
• W1998420811 date "2012-10-01" @default.
• W1998420811 modified "2023-10-17" @default.
• W1998420811 title "Illicit drugs and cluster headache: An inevitable discussion" @default.
• W1998420811 cites W1528725418 @default.
• W1998420811 cites W1999521255 @default.
• W1998420811 cites W2069945178 @default.
• W1998420811 cites W2103068721 @default.
• W1998420811 cites W2129136808 @default.
• W1998420811 cites W2148395060 @default.
• W1998420811 cites W2150275407 @default.
• W1998420811 cites W2150280237 @default.
• W1998420811 cites W2151828427 @default.
• W1998420811 cites W4251301529 @default.
• W1998420811 doi "https://doi.org/10.1177/0333102412458188" @default.
• W1998420811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23043132" @default.
• W1998420811 hasPublicationYear "2012" @default.
• W1998420811 type Work @default.
• W1998420811 sameAs 1998420811 @default.
• W1998420811 citedByCount "8" @default.
• W1998420811 countsByYear W19984208112013 @default.
• W1998420811 countsByYear W19984208112014 @default.
• W1998420811 countsByYear W19984208112018 @default.
• W1998420811 countsByYear W19984208112019 @default.
• W1998420811 countsByYear W19984208112020 @default.
• W1998420811 crossrefType "journal-article" @default.
• W1998420811 hasAuthorship W1998420811A5009170730 @default.
• W1998420811 hasBestOaLocation W19984208111 @default.
• W1998420811 hasConcept C118552586 @default.
• W1998420811 hasConcept C164866538 @default.
• W1998420811 hasConcept C199360897 @default.
• W1998420811 hasConcept C2777942821 @default.
• W1998420811 hasConcept C2778541695 @default.
• W1998420811 hasConcept C41008148 @default.
• W1998420811 hasConcept C71924100 @default.
• W1998420811 hasConceptScore W1998420811C118552586 @default.
• W1998420811 hasConceptScore W1998420811C164866538 @default.
• W1998420811 hasConceptScore W1998420811C199360897 @default.
• W1998420811 hasConceptScore W1998420811C2777942821 @default.
• W1998420811 hasConceptScore W1998420811C2778541695 @default.
• W1998420811 hasConceptScore W1998420811C41008148 @default.
• W1998420811 hasConceptScore W1998420811C71924100 @default.
• W1998420811 hasIssue "14" @default.
• W1998420811 hasLocation W19984208111 @default.
• W1998420811 hasLocation W19984208112 @default.
• W1998420811 hasOpenAccess W1998420811 @default.
• W1998420811 hasPrimaryLocation W19984208111 @default.
• W1998420811 hasRelatedWork W1598613967 @default.
• W1998420811 hasRelatedWork W1989079144 @default.
• W1998420811 hasRelatedWork W2009661139 @default.
• W1998420811 hasRelatedWork W2029615725 @default.
• W1998420811 hasRelatedWork W2031059808 @default.
• W1998420811 hasRelatedWork W2033068356 @default.
• W1998420811 hasRelatedWork W2080386122 @default.
• W1998420811 hasRelatedWork W2412425582 @default.
• W1998420811 hasRelatedWork W4210760452 @default.
• W1998420811 hasRelatedWork W4253920766 @default.
• W1998420811 hasVolume "32" @default.
• W1998420811 isParatext "false" @default.
• W1998420811 isRetracted "false" @default.
• W1998420811 magId "1998420811" @default.
• W1998420811 workType "article" @default.